•  
  •  
 

Abstract

Relative Expression of HIF-1α mRNA in Rat Heart, Brain and Blood During Induced Systemic Hypoxia. Hypoxia is a pathological condition in which the body as a whole or region of the body (tissue or cell) deprived of adequate oxygen supply. The transcriptional regulator hypoxia inducible factor-1 (HIF-1) is an essential mediator of O2 homeostasis. Unlike the β sub unit (HIF-1β), the activity of HIF-1α is controlled in an oxygen-dependent manner. It has been reported that the stability and expression of HIF-1α during hypoxia is remarkably higher than those under normoxic conditions.The aim of this study was to analyze the adaptive tissue responses during induced systemic hypoxia by comparation of relative expression of mRNA HIF-1α in rat heart, brain and blood. Twenty-five male Sprague Dawley rats were subjected to systemic hypoxia by placing them in the hypoxic chamber supplied by 8-10% of O2 for 0, 1, 7, 14 and 21 days, respectively. The relative expression level of HIF-1α mRNA in brain, heart and leucocyte cells were analyzed using quantitative RT-PCR assay (Real Time PCR) based on Pfaff’s formula. This study demonstrates that the increased of relative expression of HIF-1α mRNA during induced systemic hypoxia reached its maximum level at day 7 (in heart) or at day 14 (in brain), whereas in leucocyte cells the stimulation of HIF-1α expression was intensively maintained up to 21 days although the expression has reached the remarkably high level. We could conclude that HIF-1α as an oxygen sensing during systemic hypoxia has different capacity and sensitivity in brain, heart and blood tissues, due to the importance of oxygen homeostasis in each tissue

References

[1] A.J. Giaccia, M.C. Simon, R. Johnson. Gene & Development 18 (2004) 2183-94. [2] J.J. Haddad. Respir Res 3 (2002) 1-27. [3] A. Zagorska, J. Dulak. HIF-1: Acta Biochimica Polonica 51/3 (2004) 563-85. [4] C. Michiels. Am J Pathol 164 (2004) 1875-82. [5] H.F. Bunn, R.O. Poyton. Physiol Rev 76 (1996) 839-85. [6] G.L. Semenza. J Appl Physiol 88 (2000) 1474-80. [7] F.R. Sharp, M. Bernaudin. Neuroscience 5 (2004) 437-46. [8] G.L. Semenza. Genes & Development 14 (2000) 1983-91. [9] J.W. Lee, S.H. Bae, J.W. Jeong, S.H. Kim, K.W. Kim. Experimental and Molecular Medicine, 36/1 (2004) 1-12. [10] G.L. Semenza. Physiology 19 (2004) 176-82. [11] S. Salceda, J. Caro. J Biol Chem 272 (1997) 22642-7. [12] G. Shao, C.Y. Gao, G.W. Lu. Neurosignals 14 (2005) 255-61. [13] G. Powis, L. Kirkpatrick. Mol Cancer Ther 3/5 (2004) 647-54. [14] F.R. Sharp, R. Ran, A. Lu, Y. Tang, K.I. Strauss, T. Glass, T. Ardizzone, M. Bernaudin. NeuroRx, 1 (2004) 26-35. [15] M. Höckel, P. Vaupel. J Natl Cancer Inst 93 (2001) 266-76.

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.